SMTL ID : 4zyf.1

Discovery of NVP-CGM097 - a highly potent and selective MDM2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: Hdm2 (MDM2) complexed with NVP-CGM097

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x 4T4: (S)-1-(4-chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4S)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one(Non-covalent)

4T4.1: 16 residues within 4Å: Chain A: Q.9, L.39, F.40, L.42, G.43, I.46, M.47, Y.52, Q.57, H.58, F.71, F.76, V.78, H.81, I.84, Y.85 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.39, A:L.39, A:F.40, A:L.42, A:I.46, A:Y.52, A:F.76, A:I.84 pi-Stacking: A:F.40

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.2: 3 residues within 4Å: Chain A: K.49, D.65, L.66 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Holzer, P. et al., Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. J.Med.Chem. (2015)

Release Date

2015-07-29

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence